Carter's (NYSE:CRI) investors are sitting on a loss of 26% if they invested five years ago




  • In Business
  • 2022-11-29 18:28:02Z
  • By Simply Wall St.
 

In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market index fund. But even the best stock picker will only win with some selections. At this point some shareholders may be questioning their investment in Carter's, Inc. (NYSE:CRI), since the last five years saw the share price fall 33%. We also note that the stock has performed poorly over the last year, with the share price down 30%.

With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies.

Check out our latest analysis for Carter's

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).

While the share price declined over five years, Carter's actually managed to increase EPS by an average of 5.7% per year. Given the share price reaction, one might suspect that EPS is not a good guide to the business performance during the period (perhaps due to a one-off loss or gain). Or possibly, the market was previously very optimistic, so the stock has disappointed, despite improving EPS.

Because of the sharp contrast between the EPS growth rate and the share price growth, we're inclined to look to other metrics to understand the changing market sentiment around the stock.

The steady dividend doesn't really explain why the share price is down. While it's not completely obvious why the share price is down, a closer look at the company's history might help explain it.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

We consider it positive that insiders have made significant purchases in the last year. Even so, future earnings will be far more important to whether current shareholders make money. If you are thinking of buying or selling Carter's stock, you should check out this free report showing analyst profit forecasts.

What About Dividends?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. Arguably, the TSR gives a more comprehensive picture of the return generated by a stock. In the case of Carter's, it has a TSR of -26% for the last 5 years. That exceeds its share price return that we previously mentioned. The dividends paid by the company have thusly boosted the total shareholder return.

A Different Perspective

While the broader market lost about 19% in the twelve months, Carter's shareholders did even worse, losing 27% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 5% per year over five years. We realise that Baron Rothschild has said investors should "buy when there is blood on the streets", but we caution that investors should first be sure they are buying a high quality business. It's always interesting to track share price performance over the longer term. But to understand Carter's better, we need to consider many other factors. Case in point: We've spotted 4 warning signs for Carter's you should be aware of, and 3 of them are a bit unpleasant.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

TAT Technologies (NASDAQ:TATT) shareholders have endured a 41% loss from investing in the stock five years ago
TAT Technologies (NASDAQ:TATT) shareholders have endured a 41% loss from investing in the stock five years ago

TAT Technologies Ltd. ( NASDAQ:TATT ) shareholders should be happy to see the share price up 12% in the last month. But...

Investing in Intapp (NASDAQ:INTA) a year ago would have delivered you a 53% gain
Investing in Intapp (NASDAQ:INTA) a year ago would have delivered you a 53% gain

The simplest way to invest in stocks is to buy exchange traded funds. But investors can boost returns by picking...

Investors in Bicycle Therapeutics (NASDAQ:BCYC) have made a impressive return of 157% over the past three years
Investors in Bicycle Therapeutics (NASDAQ:BCYC) have made a impressive return of 157% over the past three years

It might seem bad, but the worst that can happen when you buy a stock (without leverage) is that its share price goes...

Is Now The Time To Look At Buying Ritchie Bros. Auctioneers Incorporated (NYSE:RBA)?
Is Now The Time To Look At Buying Ritchie Bros. Auctioneers Incorporated (NYSE:RBA)?

Ritchie Bros. Auctioneers Incorporated ( NYSE:RBA ), is not the largest company out there, but it saw a decent share...

Guardant Health (NASDAQ:GH) investors are sitting on a loss of 59% if they invested three years ago
Guardant Health (NASDAQ:GH) investors are sitting on a loss of 59% if they invested three years ago

Guardant Health, Inc. ( NASDAQ:GH ) shareholders should be happy to see the share price up 16% in the last month. But...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business